Cu64-DOTA-trastuzumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cu64-DOTA-trastuzumab, covering 2023-03-09 to 2023-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer [Phase 2]